PTC Therapeutics ( ($PTCT) ) has shared an update. On December 29, 2025, PTC Therapeutics, Inc. entered into a second amendment to its Amended and ...

Thousands of C-suite executives, researchers, entrepreneurs and government leaders convene each year to help plan what’s next for satellites, undersea cables and much of the hardware that makes the ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Dec. 16, 2025, the company approved non-statutory stock options to purchase an aggregate of 3,825 shares of its common stock and 4,385 ...

Royalty Pharma Plc (NASDAQ: RPRX) shares rose 1.5% in after-hours trading on Monday after the company announced it had ...

PTC Therapeutics has long been trying to workshop its vatiquinone into a marketable treatment for Friedreich's ataxia (FA) after a phase 3 fail in 2023. Despite its efforts, the FDA has snubbed the ...

PTC Inc. recently launched the Arena PLM and QMS AI Engine, a cutting-edge solution designed to bring AI-powered intelligence directly into core product lifecycle and quality work ...